AI-assisted, human-published
04/02/2024 /Exits
Eiger Biopharmaceuticals Files for Bankruptcy Due to Financial Challenges
Eiger Biopharmaceuticals, a company focused on rare metabolic disease therapies, files for bankruptcy, plans asset liquidation, and secures Zokinvy sale.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com